Abstract: A timepiece including: a dial; a windshield glass having a plurality of curved surfaces that differ from each other in curvature; and a hand disposed between the dial and the windshield glass, wherein the windshield glass includes: a first curved surface having a first curvature and including a center of the windshield glass; a second curved surface disposed adjacent to the first curved surface and having a second curvature larger than the first curvature; and a third curved surface disposed adjacent to the second curved surface and having a third curvature larger than the second curvature, a thickness of the first curved surface and a thickness of the second curved surface are equal, and in plan view, a distal end of the hand is disposed on a center C side of the windshield glass with respect to a boundary between the second curved surface and the third curved surface.

Abstract: A rotor includes a rotor core provided with a through hole, and a shaft fitted into the through hole. The shaft includes an arc-shaped outer peripheral portion extending along a center of the through hole, and a flat surface portion linearly cutting out at least part of a circle of the outer peripheral portion in a section orthogonal to an extending direction of the center. The through hole of the rotor core includes an inner peripheral portion that faces and is separated from the outer peripheral portion and the flat surface portion to provide a space portion, a first contact portion that is provided in the inner peripheral portion directed toward the center and contacts the flat surface portion, and second contact portions that are provided in the inner peripheral portion directed toward the center at positions away from the first contact portion and contact the outer peripheral portion.

Abstract: A rotor including a shaft, and a rotor core fixed on an outer circumferential surface of the shaft, with a key portion provided in an inner circumferential surface of the rotor core being fitted in a keyway provided in the outer circumferential surface of the shaft. The key portion includes an opposed part opposed to the keyway, wherein the opposed part is constituted by a core bottom portion, a core inclined portion and a core curved portion of the inner circumferential surface of the rotor core, which are contiguous in a circumferential direction of the rotor core. The core inclined portion and a shaft inclined portion of the outer circumferential surface of the shaft are in contact at with each other. The core curved portion and a shaft curved portion of the outer circumferential surface of the shaft cooperate to define a clearance in a radial direction of the rotor.

Abstract: A retarder-equipped rotating electrical machine includes a rotor, a stator, and a retarder rotor. The stator has teeth at regular intervals in a circumferential direction. One ends of the teeth are disposed to face the rotor. The retarder rotor has a magnetic member continuously in the circumferential direction. The retarder rotor is disposed to face the other ends of the teeth of the stator and configured to rotate integrally with the rotor. A rotor-to-stator pole piece portion having pole pieces at regular intervals in the circumferential direction is disposed between the rotor and the stator. A stator-to-retarder rotor pole piece portion having pole pieces at regular intervals in the circumferential direction is disposed between the stator and the retarder rotor. Both pole piece portions are moved in the circumferential direction to switch between an operation as a motor or generator and an operation as a retarder.

Abstract: An object of the present invention is to provide a low molecular weight compound having a prophylactic or therapeutic action on cancer. A compound of the following formula (1), a compound of the following formula (2), or the like can be administered by a method such as oral administration to prevent or treat cancers such as colorectal cancer.

Abstract: An object of the present invention is to provide an agent for enhancing fertilization function of a mammal sperm, which comprises a low molecular compound which can be produced relatively easily and inexpensively as an active ingredient, and a method for enhancing fertilization function of a mammal sperm and a method for preparing a mammal fertilized egg, which use a low molecular compound which can be produced relatively easily and inexpensively. An agent comprising one or more compounds selected from the group consisting of compounds of the following formula (I0), formula (II), and formula (III), and physiologically acceptable salts thereof when R3 is OH is used as an agent for enhancing fertilization function of a mammal sperm.

Abstract: It is to provide an agent for preventing or improving hearing loss, which comprises a low molecular compound which can be produced relatively easily and inexpensively as an active ingredient. One or more compounds selected from the group consisting of compounds represented by the following formulas (I0), (II), and (III) and a pharmaceutically acceptable salt of the compounds when R3 is OH are used as an agent for preventing or improving hearing loss.

Abstract: A retarder-equipped rotating electrical machine includes a rotor, a stator, and a retarder rotor. The stator has teeth at regular intervals in a circumferential direction. One ends of the teeth are disposed to face the rotor. The retarder rotor has a magnetic member continuously in the circumferential direction. The retarder rotor is disposed to face the other ends of the teeth of the stator and configured to rotate integrally with the rotor. A rotor-to-stator pole piece portion having pole pieces at regular intervals in the circumferential direction is disposed between the rotor and the stator. A stator-to-retarder rotor pole piece portion having pole pieces at regular intervals in the circumferential direction is disposed between the stator and the retarder rotor. Both pole piece portions are moved in the circumferential direction to switch between an operation as a motor or generator and an operation as a retarder.

Abstract: An axle device includes a power unit including an electric motor and a differential. A drive shaft transmits power distributed by the differential to a drive wheel. The drive shaft is supported by an axle pipe via a hub bearing. The right and left axle pipes are respectively fixed to right and left portions of the axle frame, and the power unit is fixed to the axle frame.

Abstract: A rotating machine and a pinion shaft are separately arranged on opposite sides to each other in the vehicle front-rear direction across a third axis that is an axis of a differential device in plan view as seen from above the vehicle. This configuration enables the rotating machine, a parallel shaft transmission, the pinion shaft, the differential device, and others to be integrally assembled to a case, to thereby configure an electric drive unit to be compact, which is advantageous in space.

Abstract: A rotating machine and a pinion shaft are separately arranged on opposite sides to each other in the vehicle front-rear direction across a third axis that is an axis of a differential device in plan view as seen from above the vehicle. This configuration enables the rotating machine, a parallel shaft transmission, the pinion shaft, the differential device, and others to be integrally assembled to a case, to thereby configure an electric drive unit to be compact, which is advantageous in space.

Abstract: The present invention provides an erythropoietin expression-enhancing agent that can cancel the suppression of erythropoietin production or promote erythropoietin production, and a therapeutic or preventive drug for anemia, a liver function-improving agent, an ischemic injury-improving agent, a renal protective agent, and an insulin secretagogue comprising the erythropoietin expression-enhancing agent. The erythropoietin expression-enhancing agent of the present invention comprises one or more compounds selected from the group consisting of compounds represented by the following general formulas (I), (II), and (III) and pharmaceutically acceptable salts thereof when R3 is OH.

Abstract: It is to provide an agent for preventing or improving hearing loss, which comprises a low molecular compound which can be produced relatively easily and inexpensively as an active ingredient. One or more compounds selected from the group consisting of compounds represented by the following formulas (I0), (II), and (III) and a pharmaceutically acceptable salt of the compounds when R3 is OH are used as an agent for preventing or improving hearing loss.

Abstract: The present invention provides an erythropoietin expression-enhancing agent that can cancel the suppression of erythropoietin production or promote erythropoietin production, and a therapeutic or preventive drug for anemia, a liver function-improving agent, an ischemic injury-improving agent, a renal protective agent, and an insulin secretagogue comprising the erythropoietin expression-enhancing agent. The erythropoietin expression-enhancing agent of the present invention comprises one or more compounds selected from the group consisting of compounds represented by the following general formulas (I), (II), and (III) and pharmaceutically acceptable salts thereof when R3 is OH.

Abstract: The present invention provides an erythropoietin expression-enhancing agent that can cancel the suppression of erythropoietin production or promote erythropoietin production, and a therapeutic or preventive drug for anemia, a liver function-improving agent, an ischemic injury-improving agent, a renal protective agent, and an insulin secretagogue comprising the erythropoietin expression-enhancing agent. The erythropoietin expression-enhancing agent of the present invention comprises one or more compounds selected from the group consisting of compounds represented by the following general formulas (I), (II), and (III) and pharmaceutically acceptable salts thereof when R3 is OH.

Abstract: A non-transitory, computer-readable recording medium stores therein, an application activation control program causing a computer to execute a process including receiving an input of a text document into an input field; and detecting completion of the input of the text document into the input field and referring to a storage device configured to store therein keywords and identification information of applications in a correlated manner, the computer further activating an application corresponding to the keyword, when a keyword is included in the received text document.

Abstract: In a hydraulic controller of driving force distribution device, including: a hydraulic circuit composed of an oil pump for supplying hydraulic fluid to a piston chamber of a clutch (or a driving force distribution device), an opening and closing valve installed in an oil passage between a check valve and the piston chamber, and an accumulator communicating to the piston chamber; control is performed so that the piston chamber reaches a target hydraulic pressure based on the 1st characteristic by closing the opening and closing valve and driving the oil pump at the time of pressurizing the piston chamber; and control is performed so that the piston chamber reaches a target hydraulic pressure based on the 2nd characteristic by prohibiting the driving of the oil pump along with opening the opening and closing valve.

Abstract: The present invention provides an erythropoietin expression-enhancing agent that can cancel the suppression of erythropoietin production or promote erythropoietin production, and a therapeutic or preventive drug for anemia, a liver function-improving agent, an ischemic injury-improving agent, a renal protective agent, and an insulin secretagogue comprising the erythropoietin expression-enhancing agent. The erythropoietin expression-enhancing agent of the present invention comprises one or more compounds selected from the group consisting of compounds represented by the following general formulas (I), (II), and (III) and pharmaceutically acceptable salts thereof when R3 is OH.

Abstract: A portable terminal includes a receiver, a barcode former configured to form barcodes and a display. The barcode former forms a barcode from the data received by the receiver and the display displays the formed barcode.

Abstract: A portable terminal includes a receiver, a barcode former configured to form barcodes and a display. The barcode former forms a barcode from the data received by the receiver and the display displays the formed barcode.